Sorted By:

Relevance


Manager - Public Affairs

PhRMA  |  PhRMA Career

Preferred Experience / Requirements Health policy experience and experience in public relations, media relations, trade association or Capitol Hill experience preferred.
https://www.phrma.org/careers/manager-public-affairs

Director – Public Affairs

PhRMA  |  PhRMA Career

Preferences Master’s degree in Health Policy, Public Policy, Communications or related field; Political and/or trade association experience Who we are The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives.
https://www.phrma.org/careers/director-public-affairs

Vice President, Public Affairs

PhRMA  |  PhRMA Career

Professional Experience / Requirements Bachelor’s degree in Public Policy, Political Science, Public Affairs or related field; Minimum of 10-15 years of experience in communications, advocacy or public affairs; Exceptional written and oral communication skills; Experience engaging with or working in the health care industry preferred; Proven experience managing and developing high performing teams.
https://www.phrma.org

Senior Director - Public Affairs

PhRMA  |  PhRMA Career

Develop plans for strategic public affairs campaigns on various issues in both international and domestic intellectual property.
https://www.phrma.org

PhRMA Comment: Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products

PhRMA  |  Speeches & Communication

PhRMA's comments in response to FDA’s notification of public hearing about manufacturer communications regarding unapproved uses of approved or cleared medical products (“FDA hearing notice”) and FDA’s Memorandum titled “Public Health Interests and First Amendment Considerations Related to Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products” (the “First Amendment Memorandum”).
https://www.phrma.org

Health Care Communications

PhRMA  |  From PhRMA

These principles are intended to form the basis for defining new and clear regulatory standards governing responsible, truthful and non-misleading communications to inform health care professionals and payers about the safe and effective use of medicines.
https://www.phrma.org/media/health-care-communications

Biopharmaceutical Company Communications with Health Care Stakeholders

PhRMA  |  Report

According to a recent survey of payer executives and specialty physicians conducted by Health Strategies Group, both payers and providers are interested in additional information from biopharmaceutical companies about prescription medicines – including information about pipeline medicines and una...
https://www.phrma.org/report/biopharmaceutical-company-communications-with-health-care-stakeholders

PhRMA Names Ieva M. Augstums as Deputy Vice President, Communications and Public Affairs

PhRMA  |  Press Release

Her wealth of experience in journalism and strategic communications will be a great asset to the team and enable her to provide fresh perspective to PhRMA’s communications and outreach activities,” says Zirkelbach.
https://www.phrma.org/press-release/phrma-names-ieva-m-augstums-as-deputy-vice-president-communications-and-public-affairs

Director - Communications

PhRMA  |  PhRMA Career

Professional Experience / Requirements Bachelor’s degree (Master’s degree in Health Policy, Public Policy, Communications or related field preferred); Health care issue experience and expertise; 5+ years of diverse communications experience including significant media relations engagement and daily pitching and responding to media; third-party stakeholder outreach and engagement; proven management of complex issues, projects, tasks, requests, and timelines; and time spent within corporate, government, public relations agency, trade association, and/or advocacy organization(s) or political campaigns; A results-oriented team player - business, political and/or trade association experience preferred with a keen understanding of organizational operations/dynamics; Ability to inspire confidence within the organization and with external constituencies; Ability to balance the needs of various internal and external parties with flexibility and a steady temperament; Must be willing to travel and be responsive/available after hours and on weekends.
https://www.phrma.org/careers/director-communications

For a Healthier America: PhRMA's Public Policy Strategy to Combat the Opioid Crisis

PhRMA  |  Policy Paper

PhRMA and its members are committed to working with other stakeholders to collectively address this growing public health crisis.
https://www.phrma.org/policy-paper/for-a-healthier-america-phrma-s-public-policy-strategy-to-combat-the-opioid-crisis

Senior Director - Public Affairs Research

PhRMA  |  PhRMA Career

Professional Experience / Requirements Bachelor’s degree in Public Policy, Political Science, Public Affairs or related field; Minimum of 5-7 years of combined experience in public research, political campaigns, issue advocacy, public affairs and/or media relations;  Exceptional written and oral communication skills;  Strong leadership and consensus-building skills; Demonstrated knowledge of federal and state legislative and regulatory processes; and Experience engaging with or working in health care or political campaigns.
https://www.phrma.org/careers/senior-director-public-affairs-research

PhRMA, member companies and NIH create public-private partnership for immuno-oncology

PhRMA  |  Blog Post

PhRMA is proud to support PACT and is hopeful that bringing together scientists and researchers from the public and private sectors will provide solutions to some of the most difficult problems in the fight against cancer.
http://catalyst.phrma.org/phrma-member-companies-and-nih-create-public-private-partnership-for-immuno-oncology

PhRMA Comments on BsUFA

PhRMA  |  Speeches & Communication

The Pharmaceutical Research and Manufacturers of America (PhRMA) is pleased to have the opportunity to respond to the Food and Drug Administration’s (FDA) request for comments on the overall performance of the Biosimilar User Fee Act (BsUFA) and to participate in the upcoming reauthorization of B...
https://www.phrma.org/public-communication/phrma-comments-on-bsufa

Josephine Martin Joins PhRMA as Exec VP of Public Affairs

PhRMA  |  Press Release

Earlier in her career, she gained in-depth health policy communications experience as Senior Vice President, Public Affairs for the Federation of American Hospitals, and Vice President of Communications at the American Red Cross.
https://www.phrma.org/press-release/josephine-martin-joins-phrma-as-exec-vp-of-public-affairs

Matt Bennett Joins PhRMA as Senior VP, Communications

PhRMA  |  Press Release

Previously, Bennett managed policy affairs on telecommunications issues for the Alliance for Public Technology, and coordinated media and external relations activities for the Alliance for Community Media.
https://www.phrma.org/press-release/matt-bennett-joins-phrma-as-senior-vp-communications

Lauren Levinson Named PhRMA Vice President of Communications

PhRMA  |  Press Release

Prior to Ketchum, Levinson worked on political campaigns and for other Washington, D.C., public affairs firms, including Prism Public Affairs and Powell Tate/Weber Shandwick Public Affairs.
https://www.phrma.org/press-release/lauren-levinson-named-phrma-vice-president-of-communications

Data Sharing Commitments will Enhance Research and Scientific Knowledge, Advance Patient Care and Improve Public Health

PhRMA  |  Press Release

“They supplement PhRMA’s Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results which were strengthened in 2004 and again in 2009.”
https://www.phrma.org/press-release/data-sharing-commitments-will-enhance-research-and-scientific-knowledge-advance-patient-care-and-improve-public-health

Sens. Portman, Cornyn, et al letter

PhRMA  |  Speeches & Communication

A group of U.S. Senators submit comments regarding the Trans-Pacific Partnership (TPP) free trade agreement negotiations....
https://www.phrma.org/public-communication/sens-portman-cornyn-et-al-letter

Growing consensus on the need to improve communications with health care professionals

PhRMA  |  Blog Post

Such communications should be based on sound scientific and statistical analysis, transparent in terms of the science and substantiation behind claims, and tailored to ensure that the message takes into account the training, expertise and capabilities of the target audience.
http://catalyst.phrma.org/growing-consensus-on-the-need-to-improve-communications-with-health-care-professionals

PhRMA Names Tina Stow as Vice President of Communications

PhRMA  |  Press Release

More broadly at APCO Worldwide, Stow managed public affairs and public positioning campaigns for Fortune 500 companies, trade associations, and nonprofit clients in multiple industry sectors designed to help build their businesses, manage and mitigate risk, and engage their stakeholders. 
https://www.phrma.org/press-release/phrma-names-tina-stow-as-vice-president-of-communications

21st Century Cures: Digital Health Care

PhRMA  |  Speeches & Communication

The Pharmaceutical Research and Manufacturers of America (PhRMA) appreciates the opportunity to provide input to the House Energy and Commerce Committee in response to the white paper entitled “21st Century Cures – Digital Health Care: Leveraging Technology to Advance the Discovery, Development, ...
https://www.phrma.org/public-communication/21st-century-cures-digital-health-care

Ethicon-Endo Surgery v. Covidien Supreme court brief on the fairness of the IPR system at the PTO

PhRMA  |  Speeches & Communication

PhRMA Amicus brief filed to U.S. Supreme Court in support of Ethicon Endo-Surgery, Inc., in the case of Ethicon-Endo Surgery v. Covidien and Michelle K. Lee, Director, U.S. Patent and Trademark Office....
https://www.phrma.org/public-communication/supreme-court-brief-fairness-of-the-ipr-system-pto

PhRMA Comment: Medical Product Communications That Are Consistent With the FDA-Required Labeling—Questions and Answers

PhRMA  |  Speeches & Communication

PhRMA's comments on the FDA's draft guidance entitled “Medical Product Communications That Are Consistent With the FDA-Required Labeling—Questions and Answers” (“Draft Guidance”).
https://www.phrma.org

Biopharmaceutical Industry Strongly Committed to Responsible Clinical Trial Data Sharing to Improve Public Health

PhRMA  |  Blog Post

Continuing to augment the amount of information available to researchers, patients and the public will expand research and scientific knowledge, foster a collaborative scientific discovery process, and support patient care – all with the ultimate goal of improving public health.
http://catalyst.phrma.org/biopharmaceutical-industry-strongly-committed-to-responsible-clinical-trial-data-sharing-to-improve-public-health

21st Century Cures: A Call to Action

PhRMA  |  Speeches & Communication

There may be no higher public health priority than accelerating the ability of researchers to navigate the long and costly discovery and development process to deliver new medicines and potential cures to patients in need.
https://www.phrma.org/public-communication/21st-century-cures-a-call-to-action

You have reviewed the first 25 results out of 881. Each page contains 25 results. You're on page 1.

prev 1 2 3 4 5 6 next